1. This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies. Learn More.
  2. All the 'News In Brief' for w/c 9th April in one post. Click here to read.
    Dismiss Notice

kpax002

  1. Andy
    Thread

    KPAX002 as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a prospective, randomized trial, 2018, Montoya et al

    Abstract: Mitochondrial dysfunction and a hypometabolic state are present in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome...
    Thread by: Andy, Apr 7, 2018, 19 replies, in forum: BioMedical ME/CFS Research
Showing results 1 to 1 of 1